The B-VAX Project
Completed
- Conditions
- Hepatitis B virus (HBV)Infections and InfestationsAcute hepatitis B
- Registration Number
- ISRCTN52272621
- Lead Sponsor
- The Burnet Institute (Australia)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 150
Inclusion Criteria
Participants who are at risk of contracting HBV (or those not already immune or infected), will be identified from existing Burnet Institute cohort studies and approached to participate.
Exclusion Criteria
Participants from Burnet Institute Cohort studies who are vaccinated or immune to HBV.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Increasing vaccine coverage amongst this cohort of people<br>2. Measuring vaccine course completion between the standard schedule and the the opportunistic accelerated schedule<br>3. Measuring immunological vaccine response between the standard schedule and the the opportunistic accelerated schedule
- Secondary Outcome Measures
Name Time Method Assessing the acceptability and feasibility of an assertive outreach model of vaccine delivery